Company intelligence / Profile preview

LinguaFlex

Pittsburgh, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

LinguaFlex is developing a minimally invasive, implantable device placed under the tongue to prevent airway obstruction caused by the tongue during sleep. The device is designed for patients with moderate-to-severe obstructive sleep apnea who are seeking alternatives to CPAP therapy. It is currently under clinical investigation and has not yet received FDA clearance[1][3][5].

Therapeutic areas: Pulmonology
Modalities: Device (implantable medical device)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on LinguaFlex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LinguaFlex.

Explore the full profile